• Je něco špatně v tomto záznamu ?

Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II

J. Tykvart, J. Schimer, A. Jančařík, J. Bařinková, V. Navrátil, J. Starková, K. Šrámková, J. Konvalinka, P. Majer, P. Šácha,

. 2015 ; 58 (10) : 4357-63. [pub] 20150507

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15031367

We present here a structure-aided design of inhibitors targeting the active site as well as exosites of glutamate carboxypeptidase II (GCPII), a prostate cancer marker, preparing potent and selective inhibitors that are more than 1000-fold more active toward GCPII than its closest human homologue, glutamate carboxypeptidase III (GCPIII). Additionally, we demonstrate that the prepared inhibitor conjugate can be used for sensitive and selective imaging of GCPII in mammalian cells.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031367
003      
CZ-PrNML
005      
20151013123159.0
007      
ta
008      
151005s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acs.jmedchem.5b00278 $2 doi
035    __
$a (PubMed)25923815
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Tykvart, Jan $u †Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo n. 2, Prague 6, 166 10, Czech Republic. ‡Department of Biochemistry, Faculty of Science, Charles University, Albertov 6, Prague 2, 128 43, Czech Republic.
245    10
$a Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II / $c J. Tykvart, J. Schimer, A. Jančařík, J. Bařinková, V. Navrátil, J. Starková, K. Šrámková, J. Konvalinka, P. Majer, P. Šácha,
520    9_
$a We present here a structure-aided design of inhibitors targeting the active site as well as exosites of glutamate carboxypeptidase II (GCPII), a prostate cancer marker, preparing potent and selective inhibitors that are more than 1000-fold more active toward GCPII than its closest human homologue, glutamate carboxypeptidase III (GCPIII). Additionally, we demonstrate that the prepared inhibitor conjugate can be used for sensitive and selective imaging of GCPII in mammalian cells.
650    _2
$a vazebná místa $7 D001665
650    _2
$a techniky syntetické chemie $7 D060326
650    _2
$a racionální návrh léčiv $7 D015195
650    _2
$a preklinické hodnocení léčiv $x metody $7 D004353
650    _2
$a inhibitory enzymů $x chemie $x metabolismus $x farmakologie $7 D004791
650    _2
$a glutamátkarboxypeptidasa II $x antagonisté a inhibitory $x chemie $x metabolismus $7 D043425
650    _2
$a HEK293 buňky $x účinky léků $7 D057809
650    _2
$a lidé $7 D006801
650    _2
$a molekulární struktura $7 D015394
650    _2
$a konformace proteinů $7 D011487
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a močovina $x chemie $7 D014508
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Schimer, Jiří $u †Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo n. 2, Prague 6, 166 10, Czech Republic. ‡Department of Biochemistry, Faculty of Science, Charles University, Albertov 6, Prague 2, 128 43, Czech Republic.
700    1_
$a Jančařík, Andrej $u †Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo n. 2, Prague 6, 166 10, Czech Republic.
700    1_
$a Bařinková, Jitka $u †Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo n. 2, Prague 6, 166 10, Czech Republic.
700    1_
$a Navrátil, Václav $u †Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo n. 2, Prague 6, 166 10, Czech Republic. ‡Department of Biochemistry, Faculty of Science, Charles University, Albertov 6, Prague 2, 128 43, Czech Republic.
700    1_
$a Starková, Jana $u †Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo n. 2, Prague 6, 166 10, Czech Republic.
700    1_
$a Šrámková, Karolína $u †Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo n. 2, Prague 6, 166 10, Czech Republic.
700    1_
$a Konvalinka, Jan $u †Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo n. 2, Prague 6, 166 10, Czech Republic. ‡Department of Biochemistry, Faculty of Science, Charles University, Albertov 6, Prague 2, 128 43, Czech Republic.
700    1_
$a Majer, Pavel $u †Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo n. 2, Prague 6, 166 10, Czech Republic.
700    1_
$a Šácha, Pavel $u †Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo n. 2, Prague 6, 166 10, Czech Republic. ‡Department of Biochemistry, Faculty of Science, Charles University, Albertov 6, Prague 2, 128 43, Czech Republic.
773    0_
$w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 58, č. 10 (2015), s. 4357-63
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25923815 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20151013123349 $b ABA008
999    __
$a ok $b bmc $g 1092243 $s 914493
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 58 $c 10 $d 4357-63 $e 20150507 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
LZP    __
$a Pubmed-20151005

Najít záznam

Citační ukazatele

Možnosti archivace